What's Happening?
The European Union is falling behind on its targets to combat antimicrobial resistance (AMR), with recent data showing an increase in drug-resistant infections. Despite having medical technologies that can help, Europe is not on track to meet its 2030
goals. The European Center for Disease Prevention & Control warns of a 'perfect storm' and calls for innovation in new medicines, lab capacity, and data-driven decision-making. The economic and health impacts of AMR are significant, with infections causing over 35,000 deaths annually in the EU and costing billions in healthcare and productivity losses.
Why It's Important?
AMR poses a major threat to global health, with the potential to undermine modern medicine. The failure to meet targets highlights the urgent need for action and investment in medical technologies that can prevent and control infections. Addressing AMR is crucial for protecting public health, reducing healthcare costs, and ensuring the effectiveness of antibiotics. The EU's struggle to meet its targets underscores the need for coordinated efforts and the adoption of innovative solutions.
